Two forms (I and II) of phosphoinositide-specific phospholipase C (PLC) were purified from the cytosol of bovine iris sphincter by sequential chromatography on DEAE-Sepharose, EAH-Sepharose, heparin-Sepharose, Sephacryl S-200 gel filtration and Mono Q HR columns. The final step resulted in specific activities of PLC-I and PLC-II of 4.3 and 5.9 ,tmol of phosphatidylinositol (PI) cleaved/min per mg of protein, which represented up to 295-fold purification compared with that of the starting supernatant. The purified enzymes were further investigated for the presence of isoenzymes and characterized for molecular mass, substrate specificity, pH, Ca2+ requirements and kinetic parameters. Using monoclonal antibodies, PLC-I was identified as PLC-81. The apparent molecular mass of PLC-I as determined by SDS/PAGE and gel filtration was 85 kDa. PLC-II contained an apparently invisible protein band that reacted with the antibody against PLC-yl, and a major 109 kDa protein band that was not recognized by any of the PLC monoclonal antibodies. Further purification of PLC-II by sizeexclusion h.p.l.c. resulted in elution of the enzyme activity as a single peak which corresponded to 109 kDa position. Again, this PLC activity was not recognized by any of the PLC monoclonal antibodies. However, the 109 kDa protein activity was recognized by a polyclonal antibody raised against a rat PLC-y1 fragment (amino acids 1272-1287), thus suggesting that this protein is a proteolytic product of PLC-y1. PLC-81 and PLC-y1 were identified in the supernatant fraction and PLC-,f1 in the membrane fraction of the iris sphincter. Although immunologically different, the catalytic properties of PLC-I and PLC-Il were quite similar. The V"ax and Km values for phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis were three to five times greater than those for PI hydrolysis. Both forms preferred PIP and PIP2 over PI and both were inactive against phosphatidylcholine. With PIP2 as substrate, the optimal pH values for PLC-I and PLC-II were 6.5 and 7.5 respectively. Unlike PIP2, PI hydrolysis by both forms was dependent on the presence of free Ca2+. The maximal hydrolysis of PI and PIP2 by both forms occurred at 200 and 5 ,tM Ca2+ respectively. Incubation of the purified enzymes with the catalytic subunit of protein kinase A (PKA) and [y-32P]ATP resulted in increased phosphorylation of PLC-I and PLC-II, but it had no inhibitory effect on their enzyme activities. PLC in iris membranes did not act as a substrate for PKA. These studies indicate that the iris sphincter smooth muscle contains PLC-y1, PLC-81, PLC-fl1 and a 109 kDa PLC which is a proteolytic product of PLC-yl. The catalytic activities of these enzymes can be affected by pH, Ca2+ concentration and probably protein phosphorylation. The functional roles of the various PLC isoenzymes in signal transduction and cyclic AMP inhibition of smooth-muscle contraction has yet to be determined.
INTRODUCTION
In smooth muscle, as in several other tissues, interactions between a number of Ca2l-mobilizing agonists and their appropriate receptors result in stimulation of phosphoinositide-specific phospholipase C (PLC), via a G-protein, and the production of the second messengers inositol 1,4,5-trisphosphate (1P3) and 1,2-diacylglycerol (DAG), from phosphatidylinositol 4,5-bisphosphate (PIP2), and contraction [1] [2] [3] [4] . In the past few years a great deal of progress has been made in the purification and characterization of PLC from a wide variety of tissues [5] [6] [7] [8] [9] . Thus PLCs have been purified and characterized from liver [10] [11] [12] , rat brain [11] [12] [13] [14] , bovine brain [15] [16] [17] [18] [19] , rabbit brain [20] , sheep seminal vesicular glands [21] , platelets [22] [23] [24] [25] [26] , porcine lymphocytes [27] , Drosophila eye [28] , rod outer segment [29] , bovine heart [30, 31] , guinea-pig uterus [32] , cultured vascular smooth muscle [33] and bovine aorta [34] . Evidence from direct protein isolation, immunological characterization and molecular cloning studies suggest the existence of four major types of PLC in mammalian tissues (a.,,8f,y and d) all of which are single polypeptides [6] . The molecular masses of these isoenzymes determined by gel-filtration chromatography and SDS/PAGE are 62-68 kDa for PLC-a, 150-154 kDa for PLC-,8, 145-148 kDa for PLC-y and 85-88 kDa for PLC-8 [6] . These isoenzymes have been shown to differ in subcellular distribution, Ca2+ requirement, pH-dependence and substrate specificity. There is accumulating evidence which indicates that PLC is coupled to its various receptors via GTP-binding proteins [35] [36] [37] [38] and that it can be regulated through protein phosphorylation [6, 39] .
We have previously investigated the properties of PLC in cytosolic and membranous fractions from rabbit iris smooth muscle [40, 41] . The PLC isoenzymes and their properties have not yet been investigated in this tissue. Recently, the occurrence of two distinct PLC forms in smooth-muscle preparations has been reported for guinea-pig uterus [32] and cultured vascular smooth-muscle cells [33] , and three forms of the enzyme were separated from the cytosol of bovine aorta [34] . Cloning techniques have identified the low-molecular-mass peaks in the uterus [32] and the vascular smooth-muscle cells [33] as PLC-a. Over the past several years we have investigated in detail the role of PLC in signal transduction in the iris smooth muscle [2, 39] , and more recently we have demonstrated that agonist-stimulated IP3 production and contraction in this tissue are inhibited by agents that raise the level of cyclic AMP (cAMP) [39] . Although the site of this inhibition is thought to be at the PLC level, its mechanism remains unknown. The purpose of the present study was: (a) to purify and characterize PLC from the bovine iris sphincter, (b) to identify, through immunoblotting, the PLC isoenzymes in this tissue, and (c) to determine whether the purified PLC can serve as a substrate for cAMP-dependent protein kinase (PKA) and to show if PLC activity is attenuated as a result of the cAMP-dependent phosphorylation.
MATERIALS AND METHODS Materials Phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP), PIP2, catalytic subunit of PKA (bovine heart), leupeptin, aprotinin and phenylmethanesulphonyl fluoride (PMSF) were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A.
Monoclonal antibodies anti-(bovine PLC-,f1), anti-(bovine PLCy1) and anti-(bovine PLC-81) were from Upstate Biotechnology Inc., Lake Placid, NY, U.S.A. A polyclonal antibody raised against a PLC-y1 fragment was a gift from Dr. Alan Tarver.
Mini-PROTEAN II Ready Gels (7.5%) for SDS/PAGE and goat anti-mouse IgG immunoblot assay kit were from Bio-Rad Laboratories, Richmond, CA, U.S.A. DEAE-Sepharose CL-6B, EAH-Sepharose 4B, heparin-Sepharose, Sephacryl S-200 and Mono Q HR 5/5 were purchased from Pharmacia Fine Chemicals, Uppsala, Sweden. TSK gel G3000SW h.p.l.c. column was purchased from TOSOHAAS, Montgomeryville, PA, U.S.A.
[3H]PI (specific radioactivity 5.2 Ci/mmol), [3H]PIP (specific radioactivity 4 Ci/mmol), [3H]PIP2 (specific radioactivity 5.4 Ci/mmol) and [y-32P]ATP (specific radioactivity 3000 Ci/mmol) were obtained from DuPont New England Nuclear, Boston, MA, U.S.A. All other chemicals used were of reagent grade.
PLC assays
During purification, PLC activity was routinely assayed by measuring the formation of radioactive inositol phosphate from [3H]PI [2, 32] . The reaction mixture, in a final volume of 100 ,ul, contained 50 mM Tris/maleate (pH 7.0), 2 mM EGTA, 0.1 mM free Ca21, 0.1 % sodium deoxycholate, 100 ,M [3H]PI (30000 d.p.m.) and an appropriate amount of the enzyme. The substrate was prepared by mixing chloroform solutions of PI and [3H]PI in an appropriate ratio and evaporating the solvent under a stream of N2. The phospholipid was suspended in the reaction buffer containing sodium deoxycholate by sonication. The reaction was initiated by addition of the enzyme preparation. The assays were conducted at 37°C for 10 min and then terminated by the addition of 0.5 ml chloroform/methanol/conc. HCl (50: 50: 0.3, by vol). This was followed by the addition of 0.15 ml 1 M HCl containing 5 mM EGTA. The reaction mixture was thoroughly mixed and centrifuged. A portion (0.4 ml) of the upper aqueous phase was removed and counted for radioactivity.
PLC activity against PIP or PIP2 was assayed as described for PI except that the substrate concentration in the reaction mixture was 240 ,M.
Preparation of soluble and microsomal membrane fractions from bovine Iris sphincter muscle Bovine eyes, obtained from a local slaughterhouse, were transported to the laboratory packed in ice. The cornea was removed and the sphincter muscle of the iris was carefully cut and washed in ice-cold buffered saline. For each preparation of PLC, we employed approx. 200 g (wet weight) of the iris sphincter. The methods of homogenization and subcellular fractionation were essentially the same as described previously [40] . Briefly, the tissues were first minced with scissors and suspended in 10 vol. of the buffer (pH 7.4) which contained 0.25 M sucrose, 10 mM Tris/HCl, 5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 0.5 mM PMSF, 10 ,ug/ml leupeptin, 5 4ag/ml aprotinin and 0.1 mM dithiothreitol (DTT). The tissues were homogenized for 4 x 30 s with a Super Dispax tissuemizer model SDT-182 (Tekmar Co.) at two-thirds of the maximum speed. The homogenate was centrifuged at 600 g for 10 min. The pellet was discarded and the supernatant centrifuged at 10000g for 30 min. The supernatant was removed and centrifuged again at 110000 g for 90 min. This yielded a soluble fraction (supernatant) and a microsomal fraction (pellet). The microsomal fraction was suspended in an appropriate volume of 50 mM Tris/maleate (pH 7.0)/50 mM KCI/2 mM EGTA/0.1 mM DTT, and the soluble fraction was dialysed overnight against 2 litres of 10 mM Tris/HCI/0.2 mM EDTA/20 % glycerol/0. I mM DTT (pH 7.6; buffer A). The dialysed soluble fraction was used as a source of PLC for purification.
Purification of PLC from the soluble fraction
The method used for purification of PLC was essentially the same as described by Bennett and Crooke [32] for guinea-pig uterus. Unless noted otherwise, all purification procedures were carried out at 4 'C.
Step 1: DEAE-Sepharose column chromatography
The dialysed supernatant was applied to a DEAE-Sepharose CL-4B column (5 cm x 20 cm) which had previously been equilibrated with buffer A. The column was washed with buffer A until the A280 returned to baseline. At this time, the column was eluted with 1200 ml of a 0-0.5 M linear concentration gradient of KCI in buffer A at a flow rate of 0.5 ml/min. Fractions (5 ml each) were collected and assayed for PLC activity. Fractions containing the enzyme activity were pooled separately for individual peaks, and then dialysed against 2 litres of 20 mM Hepes/20 mM NaCl/2 mM EGTA/20 % glycerol/0. 1 mM DTT (pH 6.8; buffer B).
Step 2: EAH-Sepharose chromatography The dialysed samples were applied to an EAH-Sepharose 4B column (2.6 cm x 19 cm) previously equilibrated with buffer B. After washing with the same buffer, the elution was carried out with a 0.02-0.55 M linear gradient of NaCl in buffer B (300 ml) at a flow rate of 0.3 ml/min. The fractions (3 ml each) were collected and assayed for the enzyme activity. The fractions containing PLC activity were pooled and dialysed against 20 mM Hepes/50 mM KCI/0.5 mM EGTA/20 % glycerol/0. 1 mM DTT (pH 6.8; buffer C).
Step 3: Heparin-Sepharose chromatography [42] . The protein bands were visualized with Coomassie Blue R-250 or transferred to nitrocellulose membrane and probed with PLC antibodies. The nitrocellulose membranes were blocked with 3 gelatin in 20 mM Tris/500 mM NaCl (pH 7.5) for 1 h at room temperature. The blocked nitrocellulose membranes were incubated with monoclonal antibodies anti-(bovine PLC-fl1), (2 jig/ml), anti-(bovine PLC-yl) (1ltg/ml) or anti-(bovine PLC-81) ( 100 Ci/mmol) in the presence or absence of a catalytic subunit of PKA at 37°C for 5 min. The reactions were stopped by adding 2 x sample buffer and proteins were processed for SDS/PAGE as described in the previous section. The radioactive protein bands corresponding to PLC were cut and counted for radioactivity.
In experiments where the effect of phosphorylation on activity of PLC was investigated, the enzyme protein was preincubated with unlabelled ATP in the presence or absence of PKA before assaying for PLC activity.
Other methods
In experiments where the effects of Ca2+ on PLC activity were to be determined, the low concentration of free Ca2l in the assay mixture was maintained by using Ca2+/EGTA buffers. The buffers contained 2 mM EGTA, and the appropriate amount of CaCl2 was added to give the desired concentration of free Ca2 . The free Ca2+ concentrations were calculated using the Bathe Constituents Program [43] . Protein concentration was determined by the method of Bradford [44] with BSA as standard.
RESULTS

Subcellular distribution of PLC in the bovine iris sphincter
To examine the subcellular distribution of PLC in the bovine iris sphincter, we assayed the enzyme activity against PI and PIP2 in the various subcellular fractions. As shown in Table 1 , the PIP2-specific PLC activity was two to three times greater than the PI-specific PLC activity in all of the subcellular fractions investigated. The specific activity of PIP2-PLC in the membranous fraction was about three times as high as that of the soluble fraction. In general, about 90 % of the total PLC activity was recovered in the soluble fraction and the remainder was associated with the membrane fraction. We employed the soluble fraction for the purification of the enzyme. 
Purification of PLC
When the dialysed 110000g supernatant was applied to the DEAE-Sepharose column and then washed with a 0-0.5 M linear gradient of KCI, the PLC activity was separated into two peaks ( Figure 1 (Figure 2a ) and PLC-I1 ( Figure  2b) were eluted from the column with apparent molecular masses of 92 kDa and 109 kDa respectively. The peak fractions were pooled, concentrated and then chromatographed on a Mono Q HR 5/5 ion-exchange f.p.l.c. column. On elution, several protein peaks emerged from the column, but the PLC-I (Figure Table 2 Purification of PLC-I and PLC-Il from bovine iris sphincter smooth muscle
The PLC activity after each purification step was determined using PI as substrate as described in the Materials and methods section. Although PLC-I and PLC-II were eluted at different positions in column chromatography indicating that we are dealing with two isoenzymes, the purity and identity of the PLCs were investigated by means of SDS/PAGE and immunoblotting. Figure 4(a) shows SDS/PAGE analysis of PLC-I and PLC-Il. One major protein band corresponding to a molecular mass of 85 kDa and a minor band corresponding to a molecular mass of 54 kDa were observed in PLC-I. In PLC-II there was one major protein band corresponding to a molecular mass of 109 kDa and one minor band in the 76 kDa region. When samples from the 110000 g supematant and deoxycholate extracts from the membrane fraction were subjected to SDS/PAGE, several protein bands of varying molecular mass were observed (results not shown). The separated proteins from PLC-I, PLC-Il, 110000 g supernatant and microsomal membrane fractions were transferred to nitrocellulose paper and probed with monoclonal antibodies raised against PLC-fl,1, -y, and -8, from bovine brain. As can be seen from Figure 4b, Table 3 , both enzymes hydrolysed all three phosphoinositides; however, the activities against PIP and PIP2 were substantially 
Effects of pH on PLC-I and PLC-Il activities
The effect of pH on PLC-I and PLC-II activities was investigated over a pH range of 5.0-8.5 with Tris/maleate buffer. The assay mixture contained either 100 ,uM P1 or 240 ,uM PIP2 with free Ca2+ concentration maintained at 100 ,uM. As shown in Figure 6 , when PI was the substrate, both PLC-I (Figure 6a ) and PLC-II (Figure 6b) showed little enzyme activity below pH 6.5. As the pH was raised, the PLC activity increased rapidly to a maximum at pH 7.0-7.5. This was followed by a rapid decline in enzyme activity as the pH was raised above 7.5. When PIP2 was used as a substrate, PLC-I hydrolysed the phospholipid at pH 5.0-6.0 at a rate which was about 60°%/ of the maximum hydrolysis observed at pH 6.5. The enzyme activity declined rapidly at higher pHs. In contrast with PLC-I, PLC-II showed little activity against PIP2 at pH values below 5.5 but increased rapidly to a broad pH optimum with nearly constant enzyme activity between pH 6.5 and 8.0.
Ca2l requirement for PLC activity
The requirement for Ca2+ in PLC-mediated hydrolysis of PI and PIP'-was investigated by using EGTA/Ca2l buffers. The ratios of Ca2+ to EGTA were varied to maintain low concentration of free Ca2+ in the standard assay mixtuwe. As shown in Figure 7 , The activities of PLC-I and PLC-Il were determined by using either 100 uM Pi or 240 ,uM PIP2 as substrates. The free Ca2+ concentration in the assay mixture was 0.1 mM and Tris/maleate buffer was used to maintain the pH. The data were expressed as the means+S.E.M. for two separate experiments each conducted in triplicate.
when PI was the substrate, both PLC-I and PLC-II showed an absolute requirement for Ca2+. Addition of 2 mM EGTA abolished PI hydrolysis and this was restored by addition of 1 ,uM free Ca2+. Increasing the free Ca2+ concentration resulted in a moderate increase in enzyme activity reaching a plateau at 1 mM Ca2+. The half-maximal activity was attained at about 2 ,uM free Ca2+ for both PLC-I and PLC-IL. In contrast with PI, when PIP2 was used as a substrate, significant hydrolysis of the phospholipid occurred in the absence of Ca2+ (Figure 7 ). In the presence of 2 mM EGTA, PIP2 hydrolysis by PLC-I and PLC-Il was 20 and 8 % of their maximal rate respectively. Addition of 0.1 ,uM free Ca2+ resulted in a large increase in enzyme activity, maximal PIP2 hydrolysis being elicited at 5 ,M free Ca2+ concentration. Half-maximal activities of PLC-I and PLC-II were observed at 50 nM and 100 nM free Ca2-respectively.
Higher concentrations (> 10#,M) of Ca2+ exerted inhibitory effects on PIP2 hydrolysis by both enzymes (Figure 7) . PLC-I and PLC-II were further characterized for molecular mass, substrate specificity, pH, Ca2+ requirements and kinetic parameters. The molecular mass of PLC-I, as determined by gel filtration and SDS/PAGE, was 85 kDa, which corresponds to that of PLC-81 in brain [6, 9] , and this is in accord with its identification by immunoblotting in the present work. Anti-(PLC-81) antibodies detected an 85 kDa PLC in bovine heart homogenate [31] . Thus the 85 kDa PLC in heart and in iris sphincter could be the same as the PLC-81 from brain [6] . The major band in PLC-II had a molecular mass of 109 kDa. In addition, there was a minor protein band in this preparation which corresponded to 76 kDa.
Although immunologically different, the catalytic properties of PLC-I and PLC-I1 were quite similar. Both isoenzymes preferred PIP and PIP2 as substrate as compared with PI, whereas phosphatidylcholine was not hydrolysed by these enzymes. PLCs from guinea-pig uterus [32] and from bovine aorta [34] also preferentially hydrolysed PIP and PIP2 as compared with PI, but the higher-molecular-mass (158 kDa) PLC from vascular smooth muscle showed much greater activity against PI than PIP2 [33] . In general, the apparent Km and Vmax values for PIP2 hydrolysis were three to five times higher than those for PI hydrolysis by both PLC-I and PLC-II. These data are consistent with kinetic data obtained from other PLC isoenzymes purified from various tissues [15, 31, 32] . With PIP2 as substrate, the optimal pH values for PLC-I and PLC-Il were 6.5 and 7.5 respectively. PLC-a from guinea-pig uterus exhibited a biphasic pH optimum using PI as a substrate, showing a major peak of activity between pH 6.0 and 7.0. Changing the free Ca2+ concentration from 4 ,uM to 1 mM did not change the biphasic character of the pH profile. PLC from vascular smooth-muscle cells had a pH optimum for PIP2 hydrolysis of 5.5-7.0, depending on the Ca2+ concentration [33] . In the bovine iris sphincter, hydrolysis of PI, but not of PIP2, by PLC-I and PLC-lI was dependent on the presence of free Ca2+ in the assay mixture. The maximal hydrolysis of PI and PIP2 by these enzymes occurred at 200 and 5,uM of the cation respectively. In general, in most tissues that have been investigated, PIP2 hydrolysis occurred at a higher pH and at a lower Ca2+ concentration than did PI hydrolysis.
Our previous studies implicated PKA in the inhibitory effects of isoprenaline and forskolin on carbachol-induced IP3 production and contraction in the iris sphincter [39, 47] . This suggests a cross-talk between the two second-messenger systems. One possible target site for PKA action is PLC. Phosphorylation of PLC could inhibit the activity of the enzyme and reduce 1P3 production and consequently lead to muscle relaxation. Incubation of PLC preparations with the catalytic subunit of PKA and [y-32P]ATP resulted in increased phosphorylation of PLC-I and PLC-II, but it had no inhibitory effect on the catalytic activities of the enzymes. PLC in membrane fractions from the iris sphincter did not act as a substrate for PKA. Although direct phosphorylation of PLC by PKA is a possibility, the mechanism by which cAMP blocks enhanced PIP2 turnover and contraction in smooth muscle remains unknown.
In summary, we have purified two different forms (I and II) of PLC from bovine iris sphincter, investigated their properties, and for the first time identified multiple PLC isoenzymes including a 109 kDa PLC which did not react with any of the PLC monoclonal antibodies, but did react with a polyclonal antibody raised against a rat PLC-71 fragment. The /1 isoenzyme was found to be associated with the membrane fraction, whereas both 81 and y1 are localized in the cytosol. Whether in this tissue IA is the isoenzyme which is involved in signal transduction remains to be determined. Previously, we reported that PLC in the microsomal fraction of bovine sphincter could be stimulated by carbachol in the presence of low concentrations of GTP [S] and Cal' [48] . Phosphorylation of PLC isoenzymes by PKA may regulate the sphincter PLC activity and play a role in the inhibition of IP3 production and consequently in muscle relaxation. However, further studies are needed to determine the target site of cAMP inhibition.
